Artificial pancreas system better controls blood glucose levels than current technology

A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.

Read more

High-salt diet promotes cognitive impairment through the Alzheimer-linked protein tau

Investigators sought to understand the series of events that occur between salt consumption and poor cognition and concluded that lowering salt intake and maintaining healthy blood vessels in the brain may 'stave off' dementia. Accumulation of tau deposits has been implicated in the development of Alzheimer's disease in humans.

Read more

Bed time is the best time to take blood pressure medication

People with high blood pressure who take all their anti-hypertensive medication in one go at bedtime have better controlled blood pressure and a significantly lower risk of death or illness caused by heart or blood vessel problems, compared to those who take their medication in the morning, according to new research.

Read more

Gene mutation in the chloride channel triggers rare high blood pressure syndrome

When the adrenal gland produces too much aldosterone, this often leads to high blood pressure and kidney damage (hyperaldosteronism). It has only recently emerged that several patients harbor a mutation in the gene for the ClC-2 chloride channel. Researchers have now been able to show for the first time how the altered channels cause the disease.

Read more

Tissue damage caused by a heart attack to be reduced by 30%?

A heart attack is caused by a clot that blocks the artery blood flow. Under these conditions, the affected tissues undergo a rapid necrosis. But why? Scientists discovered that the synthesis of a lipid provokes the necrosis. This lipid accumulates in the absence of oxygen and blocks cellular functions. By inhibiting its synthesis in a mouse suffering a heart attack, the biologists were able to reduce the tissue damage by 30%.

Read more

Treating pulmonary embolism: How safe and effective are new devices?

A new scientific statement identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism. Authors conclude there is little data — particularly, as it pertains to the treatment of patients with 'intermediate-risk PE' — that suggests these interventional approaches are more safe and effective than the use of anticoagulation alone.

Read more

Ibrutinib linked to high blood pressure and other heart problems, study suggests

Over half of people prescribed the targeted blood cancer-fighting drug ibrutinib developed new or worsened high blood pressure within six months of starting the medication. The analysis is also the first to tie ibrutinib-related hypertension to a heightened risk of heart problems, particularly atrial fibrillation. Moreover, the association of ibrutinib with cardiovascular complications remained regardless of the prescribed dose.

Read more

Nanoparticles wiggling through mucus may predict severe COPD

In a proof-of-concept experiment, researchers say they have successfully used microscopic human-made particles to predict the severity of patients' chronic obstructive pulmonary disease (COPD) by measuring how quickly the particles move through mucus samples. The technique, say the researchers, could eventually help doctors deliver more effective treatments sooner.

Read more